Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Lam Research Earnings Highlights: Solid Performance Amidst Industry Transitions

by Team Lumida
August 2, 2024
in Equities
Reading Time: 9 mins read
A A
0
Lam Research Earnings Highlights: Solid Performance Amidst Industry Transitions
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Top Takeaways

  1. Lam Research delivered strong Q4 2024 results, exceeding guidance on revenue, profitability, and earnings per share.
  2. The company is well-positioned to capitalize on the increasing etch and deposition intensity in semiconductor manufacturing, particularly in AI-related applications.
  3. CSBG business showed robust growth, with revenues up 22% sequentially, indicating improving industry utilization rates.
  4. Lam Research expects WFE spending to be in the mid $90 billion range for 2024, with growth anticipated across foundry logic, DRAM, and NAND investments.
  5. The company is making strategic investments in product development, global R&D infrastructure, and digital transformation to drive future growth and operational efficiency.

Summary

Lam Research reported solid Q4 2024 results, with revenues, profitability, and earnings per share all exceeding the midpoint of guidance. The company’s CSBG business posted strong growth, with revenues up 22% sequentially, led by Reliant and spares. CEO Timothy Archer highlighted the company’s strategic investments and positioning for future growth:

“We believe these investments will put Lam in a position to outperform as the industry moves into a period of multiyear WFE spending expansion.”

Main Themes

  • Guidance: WFE spending expected to be in the mid $90 billion range for 2024
  • New Product Announcements: Introduction of Lam Cryo 3.0, third-generation cryogenic etch technology
  • AI References: Increasing focus on AI-related applications driving demand for GPUs and HBM
  • Market Outlook: Positive environment for continued growth in WFE spending in 2025
  • Economic Outlook: Anticipation of expanding AI use cases spurring content growth in low-power DRAM and NAND storage

Insights

Lam Research is strategically positioning itself to capitalize on the increasing etch and deposition intensity in semiconductor manufacturing. The company’s focus on developing critical solutions for atomic-level device scaling, new materials innovation, and advanced packaging integration is expected to expand its served market and increase market share at each successive process technology node.

Market Opportunity

The company sees significant growth opportunities in AI-related applications, with a focus on:

  1. Gate-all-around technology
  2. Backside power delivery
  3. Advanced packaging
  4. High-bandwidth memory (HBM)

Each of these areas represents a $1 billion or higher growth opportunity for Lam Research.

Market Commentary

The semiconductor industry is experiencing a shift towards AI-enabled technologies, driving demand for more advanced and efficient manufacturing processes. Lam Research expects memory customers to focus on technology upgrades of the installed base to scale capacity and lower bit costs. This trend is particularly favorable for Lam, given its significant installed base in memory manufacturing.

“When you consider Lam’s sizable installed base in memory, including roughly 7,500 high aspect ratio dielectric etch chambers for NAND alone, we are positioned to outgrow overall WFE when customers upgrade existing memory production lines to next-generation nodes.”

Customer Behaviors

Customers are increasingly focusing on technology upgrades rather than greenfield investments, particularly in the memory sector. This shift benefits Lam Research due to the higher etch and deposition intensity required for upgrades compared to new fab construction.

Capex

  • Capital expenditures for Q4 2024: $101 million
  • Focus areas: Lab investments in the United States and Asia, manufacturing facilities in Asia

Industry Insights

The semiconductor industry is experiencing a transition towards more advanced manufacturing processes, driven by AI applications and the need for more efficient and powerful chips. This shift is expected to benefit companies like Lam Research that specialize in critical manufacturing technologies such as etch and deposition.

Key Metrics

Financial Metrics

  • Revenue: $3.87 billion (above midpoint of guidance)
  • Gross margin: 48.5% (top end of guided range)
  • Operating margin: 30.7% (above guidance range)
  • Earnings per share: $8.14 (close to high end of guidance range)

KPIs

  • CSBG revenue: $1.7 billion (up 22% sequentially, 14% YoY)
  • Deferred revenue balance: $1.55 billion

“For fiscal year 2024, we achieved the highest gross margin percentage since the merging of Lam with Novellus in 2013, coming in at 48.2% and we generated quite strong free cash flow of approximately $4.3 billion or 29% of revenue.”

Competitive Differentiators

  1. Strong position in etch and deposition technologies
  2. Large installed base in memory manufacturing
  3. Advanced cryogenic etch technology (Lam Cryo 3.0)
  4. Innovative PECVD-based pure carbon gap fill process
  5. Global manufacturing and R&D infrastructure close to customers

Key Risks

  1. Potential changes in export controls affecting China business
  2. Cyclical nature of the semiconductor industry
  3. Dependence on memory market recovery
  4. Intense competition in the semiconductor equipment industry
  5. Geopolitical tensions affecting global supply chains

Analyst Q&A Focus Areas

  1. China business outlook and potential impact of export controls
  2. DRAM and NAND market recovery expectations
  3. Advanced packaging and HBM revenue projections
  4. Gross margin trends and customer mix impact
  5. CSBG business growth sustainability

Lam Research Summary:

Lam Research is well-positioned to capitalize on the increasing importance of etch and deposition technologies in advanced semiconductor manufacturing. The company’s focus on AI-related applications, memory upgrades, and new product innovations should drive growth in the coming years. Investors should watch for the recovery in the NAND market, the ramp-up of advanced packaging technologies, and the impact of potential export control changes on the company’s China business.

Tags: $LRCXEARNINGS
Previous Post

Intercontinental Exchange (ICE) Q2 2024 Earnings Highlights: Record-Breaking Performance Across Multiple Segments

Next Post

Meta Platforms Q2 2024 Earnings Highlights: Strong Quarter with AI-Driven Growth

Recommended For You

Hon Hai (Foxconn) July Sales Miss Signals Tariff Impact on Nvidia AI Server Partner

by Team Lumida
16 hours ago
nvidia graphics processing unit

Key Data & Insights: Powered by lumidawealth.com Sales Slowdown: Hon Hai's July sales rose just 7.25% to NT$613.8 billion ($20.5 billion)—its weakest growth since January and well below the...

Read more

UBS Launches New Euro Bond Sale After Earnings Beat, Extending Post-Credit Suisse Debt Spree

by Team Lumida
16 hours ago
UBS logo on glass bridge wall during daytime

Key Data & Insights: Powered by lumidawealth.com Fresh Euro Debt: UBS is issuing two tranches of euro-denominated senior HoldCo notes—six-year (at ~120bps over midswaps) and 11-year (at ~150bps over...

Read more

Shell Maintains $3.5 Billion Buyback Despite Earnings Decline

by Team Lumida
6 days ago
low angle photography of Shell gas station at night

Key Takeaways: Powered by lumidawealth.com Earnings Decline: Shell’s Q2 adjusted earnings fell 24% to $4.26 billion from $5.58 billion in the previous quarter but beat analyst expectations of $3.74...

Read more

Unilever Beats Q2 Underlying Sales Expectations, Confirms Full-Year Outlook

by Team Lumida
6 days ago
Unilever Beats Q2 Underlying Sales Expectations, Confirms Full-Year Outlook

Key Takeaways: Powered by lumidawealth.com Sales Growth: Unilever’s underlying sales rose 3.8% in Q2, surpassing analyst expectations of 3.6%, driven by strong demand across all business segments. Turnover Decline:...

Read more

Porsche Cuts 2025 Guidance Again After $1.27 Billion Tariff Hit

by Team Lumida
7 days ago
running black Porsche sedan

Key Takeaways: Powered by lumidawealth.com Tariff Impact: Porsche took a €400 million ($461.9 million) hit from U.S. import tariffs in H1 2025, opting not to pass costs to customers,...

Read more

UBS Posts Strong Q2 Profit as Market Volatility Boosts Trading Revenue

by Team Lumida
7 days ago
UBS Posts Strong Q2 Profit as Market Volatility Boosts Trading Revenue

Key Takeaways: Powered by lumidawealth.com Profit More Than Doubled: UBS reported a Q2 net profit of $2.395 billion, more than doubling from $1.14 billion a year earlier and beating...

Read more

Adidas Shares Drop After Lower-Than-Expected Q2 Sales and Tariff-Related Uncertainty

by Team Lumida
7 days ago
Adidas logo

Key Takeaways: Powered by lumidawealth.com Sales Miss: Adidas reported Q2 sales of €5.95 billion, up 2.2% year-over-year but below analyst expectations of €6.15 billion. Profit Growth: Net profit rose...

Read more

AstraZeneca Reports Strong Q2 Sales and Profit Boosted by Cancer Drugs

by Team Lumida
1 week ago
AstraZeneca Reports Strong Q2 Sales and Profit Boosted by Cancer Drugs

Key Takeaways: Powered by lumidawealth.com Revenue Growth: AstraZeneca’s Q2 revenue rose 12% to $14.5 billion, surpassing analyst estimates. Earnings: Adjusted earnings per share increased 10% to $2.17, in line...

Read more

Whirlpool Cuts Dividend and Lowers Full-Year Profit Guidance Amid Tariff Pressures

by Team Lumida
1 week ago
Whirlpool Cuts Dividend and Lowers Full-Year Profit Guidance Amid Tariff Pressures

Key Takeaways: Powered by lumidawealth.com Profit Outlook Slashed: Whirlpool lowered its full-year adjusted earnings per share (EPS) guidance to $6-$8 from $10, missing analyst expectations of $8.96. Dividend Cut:...

Read more

Boston Beer Cuts Tariff Impact Estimate as Q2 Profit Rises Despite Volume Decline

by Team Lumida
1 week ago
Boston Beer Cuts Tariff Impact Estimate as Q2 Profit Rises Despite Volume Decline

Key Takeaways: Reduced Tariff Impact: Boston Beer lowered its full-year tariff cost estimate to $15-20 million ($0.96-$1.28 per share) from the previous $20-30 million range, citing more moderate...

Read more
Next Post
a white square with a blue logo on it

Meta Platforms Q2 2024 Earnings Highlights: Strong Quarter with AI-Driven Growth

Procter & Gamble Earnings Highlights: Strong Performance Amidst Global Challenges

Procter & Gamble Earnings Highlights: Strong Performance Amidst Global Challenges

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

boats on the sea near buildings during daytime

The Panama Canal’s Growing Importance in U.S. Energy Exports

April 3, 2025
Israel-Iran Conflict Revives China’s Interest in Russian Gas Pipeline Amid Energy Security Concerns

Israel-Iran Conflict Revives China’s Interest in Russian Gas Pipeline Amid Energy Security Concerns

June 25, 2025
apple, nvidia, microsoft

Nvidia, Microsoft, and Apple Surpass Entire Chinese Stock Market

June 6, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018